市場調查報告書
商品編碼
1349210
心臟封堵裝置市場 - 依產品(心房中隔缺損 (ASD) 封堵裝置、左心耳 (LAA) 封堵裝置)、依材質(鎳鈦諾基裝置、不鏽鋼裝置)、交付方式、最終用途及預測, 2023 - 2032Heart Closure Devices Market - By Product (Atrial Septal Defect (ASD) Closure Devices, Left Atrial Appendage (LAA) Closure Devices), By Material (Nitinol-based Devices, Stainless Steel Devices), Mode of Delivery, End-use & Forecast, 2023 - 2032 |
2023年至2032年,全球心臟閉合裝置市場的年複合成長率將達到12.2%。全球心血管疾病發生率的上升推動了對微創手術的需求。據世界衛生組織指出,每年,心血管疾病 (CVD) 導致全球約 1,790 萬人死亡,鞏固了其作為主要死因的地位。
經皮封堵心房中隔缺損和卵圓孔未閉等手術推動了對心臟封堵裝置的需求。此外,技術進步提高了這些設備的安全性和有效性,吸引了患者和醫療保健提供者,促進了市場成長。此外,人口老化的加劇以及人們對這些設備益處的認知不斷增強,將增強心臟閉合設備的市場前景,直至2032年。
整個心臟閉合裝置市場根據產品、材料、最終用途和地區進行分類。
就產品而言,2023年至2032年,房間隔缺損(ASD)細分市場將以12.6%的年複合成長率擴張。ASD是一種先天性心臟病,心房之間存在孔洞,導致血流異常。這些裝置(例如房間隔封堵器)提供了一種微創解決方案來閉合缺損,降低併發症的風險並改善患者的生活品質。隨著人們對自閉症譜系障礙 (ASD) 認知的不斷提高和設備技術的進步,對治療這種疾病的心臟閉合設備的需求穩步成長。
從材料來看,從2023年到2032年,另一個細分市場的年複合成長率將達到12.5%。對改善生物相容性和降低患者過敏或不良反應風險的需求推動該細分市場的成長。生物可吸收聚合物和鈦合金等材料因其良好的特性而越來越受歡迎。這些材料不僅提高了患者的安全性,還為微創手術提供了創新的解決方案,將市場範圍擴大到傳統選擇之外。
就最終用途而言,心導管實驗室細分市場在2023年至2032年期間的年複合成長率將達到 12.3%。心導管實驗室處於微創心臟手術的最前線。心臟閉合裝置,如房間隔封堵器和血管塞,擴大在此類環境中使用,以治療房間隔缺損和卵圓孔未閉等疾病。它們的有效性、安全性和縮短的恢復時間使它們成為這些專業設施中不可或缺的工具。
從地區來看,2023年至2032年,亞太地區心臟閉合裝置市場的年複合成長率將達到13.3%。由於各國心血管疾病盛行率不斷上升,推動了對微創治療方案的需求,該市場蓬勃發展。此外,隨著人口老化的加劇,醫療保健基礎設施的改善和醫療保健意識的提高也有助於市場的擴張。隨著亞太地區繼續優先考慮心血管健康,心臟閉合裝置市場收入將在未來幾年大幅成長。
Global Heart Closure Devices Market will witness a 12.2% CAGR between 2023 and 2032. The rising incidence of cardiovascular diseases worldwide has propelled the demand for minimally invasive procedures. According to WHO, each year, cardiovascular diseases (CVDs) are responsible for approximately 17.9 million fatalities worldwide, solidifying their position as the leading cause of death.
Procedures like percutaneous closure of atrial septal defects and patent foramen ovale propel the need for heart closure devices. Additionally, technological advancements have improved the safety and efficacy of these devices, attracting both patients and healthcare providers, thus contributing to market growth. Moreover, the increasing aging population and growing awareness of the benefits of these devices will strengthen the heart closure devices market outlook through 2032.
The overall Heart Closure Devices Market is classified based on product, material, end-use, and region.
With respect to product, the Atrial Septal Defect (ASD) segment will expand at a 12.6% CAGR from 2023 to 2032. ASD is a congenital heart condition in which a hole exists between the atria, leading to abnormal blood flow. These devices, such as septal occluders, offer a minimally invasive solution to close the defect, reducing the risk of complications and improving patients' quality of life. With growing awareness of ASD and advancements in device technology, the demand for heart closure devices in managing this condition is steadily increasing.
By material, the other segment will register a 12.5% CAGR from 2023 to 2032. The need for improved biocompatibility and reduced risk of allergies or adverse reactions in patients is driving segment growth. Materials like bioabsorbable polymers and titanium alloys are gaining popularity due to their favorable attributes. These materials not only enhance patient safety but also offer innovative solutions for minimally invasive procedures, expanding the market's scope beyond traditional choices.
Regarding the end-use, the cardiac catheterization laboratories segment will exhibit a 12.3% CAGR over 2023-2032. Cardiac catheterization labs are at the forefront of minimally invasive cardiac procedures. Heart closure devices, like septal occluders and vascular plugs, are increasingly utilized in such settings to treat conditions like atrial septal defects and patent foramen ovale. Their effectiveness, safety, and reduced recovery times make them essential tools in these specialized facilities.
Regionally, the Asia Pacific heart closure devices market will record a 13.3% CAGR from 2023 to 2032. The market is thriving due to the increasing prevalence of cardiovascular diseases in countries driving the need for minimally invasive treatment options. Additionally, improving healthcare infrastructure and rising healthcare awareness, in line with the growing aging population, are contributing to the market expansion. As the Asia-Pacific region continues to prioritize cardiovascular health, the heart closure devices market revenue is set for substantial growth in the coming years.